This project will establish a flexible and accessible medtech/pharma clinical manufacturing facility to enable the translation of innovative, investigational products into clinical studies.
Secondly, the project will establish a hands-on competency based training facility suitable for researchers and industry to improve their understanding of the medtech/pharma manufacturing requirements utilising state of the art equipment.
In addition, the project aims to integrate both the clinical manufacture and training objectives to further reduce costs, time to clinic and upskill education and employment opportunities.
Outcomes: The manufacturing facility at TRI is now operational with over 25 individuals and 4 companies using the facility, over 15 new enquiries and a commitment of $60 million from the Queensland government to support a larger facility to further scale manufacturing to later stage clinical trials.
|Consortium lead||Translational Research Institute|
|Consortium members||VAXXAS, PharmOut & Eurofins AMS|
|Project duration||February 2018 - February 2020 (Finished)|
|Contact||Michelle Richards, Translational Research Institute - Michelle.Richards@tri.edu.au|
Charles Ross, Vaxxas - firstname.lastname@example.org
Visit Translational Research Institute for more details.
Watch a promotional video of the TRI's Cleanrooms:
Watch a tour of the Cleanrooms: